◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
Home › All stocks › 0-9 › 2493

Mabwell (Shanghai) Bioscience Co., Ltd. (2493) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Biotechnology · DATA UPDATED 2026-09-30

Mabwell (Shanghai) Bioscience Co., Ltd. (2493) operates in the Biotechnology industry and is headquartered in Shanghai, China with about 1,356 employees. Its market capitalization is roughly HK$9 billion. In the fiscal year ended 2025-12-31, 2493 reported CNY 662M in revenue and (CNY 969M) in net income.

Mabwell (Shanghai) Bioscience Co., Ltd., a biopharmaceutical company, engages in the research and development, manufacture, and commercialization of biological products for oncology, immunology, bone disorders, ophthalmology, hematology, and infectious diseases in China and internationally.

Interactive charts & full statements → Open the 2493 valuation workbench →

2493 Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total RevenueCNY 662MCNY 200MCNY 128MCNY 28M—
Gross ProfitCNY 598MCNY 171MCNY 126MCNY 28M—
Operating Income (EBIT)(CNY 851M)(CNY 995M)(CNY 1.1B)(CNY 991M)—
Net Income(CNY 969M)(CNY 1.0B)(CNY 1.1B)(CNY 955M)—

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

2493 Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-06-302025-03-31
Total RevenueCNY 185MCNY 128MCNY 97MCNY 56MCNY 45M
Gross ProfitCNY 139MCNY 97MCNY 71MCNY 45MCNY 35M
Operating Income (EBIT)(CNY 241M)(CNY 198M)(CNY 339M)(CNY 240M)(CNY 269M)
Net Income(CNY 280M)(CNY 242M)(CNY 372M)(CNY 260M)(CNY 292M)

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

2493 Free Cash Flow History

Cash flow2025-12-312024-12-312023-12-312022-12-31
Dividends Paid(CNY 78M)(CNY 66M)(CNY 34M)(CNY 13M)

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

2493 Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-06-302026-03-312025-12-312025-06-302025-03-31
Dividends Paid(CNY 23M)(CNY 24M)(CNY 20M)(CNY 18M)(CNY 23M)

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

2493 Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total AssetsCNY 4.6BCNY 4.3BCNY 4.5BCNY 4.6B—
Total LiabilitiesCNY 4.0BCNY 2.7BCNY 1.9BCNY 1.1B—

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 2493 viewer.

Other Companies in Biotechnology

← 2492All “0-9” companies2495 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.